{"result": "(\"entity\"<|>CRITICAL ILLNESS<|>EVENT<|>Critical illness refers to a state of health requiring intensive medical care, often involving nutritional support to aid recovery.)\n##\n(\"entity\"<|>NUTRITIONAL SUPPORT<|>EVENT<|>Nutritional support encompasses the provision of nutrients to patients, particularly those who are critically ill, to improve health outcomes.)\n##\n(\"entity\"<|>SOJA<|>EVENT<|>Soja refers to soybean, which is mentioned in the context of nutritional formulations and its omega-6 fatty acid content.)\n##\n(\"entity\"<|>OMEGA-3<|>EVENT<|>Omega-3 refers to a type of fatty acid that is beneficial for critically ill patients, particularly from sources like fish oil.)\n##\n(\"entity\"<|>OMEGA-6<|>EVENT<|>Omega-6 refers to a type of fatty acid that is often found in soybean oil and is recommended to be reduced in critical care nutrition.)\n##\n(\"entity\"<|>HYPERMETABOLIC STATE<|>EVENT<|>A hypermetabolic state is a condition often seen in critically ill patients, leading to increased nutritional requirements.)\n##\n(\"entity\"<|>TRACER ELEMENTS<|>EVENT<|>Tracer elements are micronutrients that are essential for various bodily functions and must be included in nutritional support.)\n##\n(\"entity\"<|>TIAMINA<|>EVENT<|>Tiamina, or thiamine, is a micronutrient recommended for supplementation in critically ill patients at risk of deficiency.)\n##\n(\"relationship\"<|>CRITICAL ILLNESS<|>NUTRITIONAL SUPPORT<|>Nutritional support is crucial for patients experiencing critical illness to aid in their recovery<|>9)\n##\n(\"relationship\"<|>SOJA<|>NUTRITIONAL SUPPORT<|>Soja is mentioned in the context of nutritional formulations that are advised against in critical care<|>5)\n##\n(\"relationship\"<|>OMEGA-3<|>NUTRITIONAL SUPPORT<|>Omega-3 fatty acids are recommended for inclusion in nutritional support for critically ill patients<|>6)\n##\n(\"relationship\"<|>OMEGA-6<|>NUTRITIONAL SUPPORT<|>Omega-6 fatty acids are advised to be reduced in nutritional support for critically ill patients<|>5)\n##\n(\"relationship\"<|>HYPERMETABOLIC STATE<|>NUTRITIONAL SUPPORT<|>A hypermetabolic state increases the nutritional requirements for critically ill patients<|>7)\n##\n(\"relationship\"<|>TRACER ELEMENTS<|>NUTRITIONAL SUPPORT<|>Tracer elements are essential components of nutritional support for critically ill patients<|>7)\n##\n(\"relationship\"<|>TIAMINA<|>NUTRITIONAL SUPPORT<|>Tiamina is recommended for supplementation in nutritional support for critically ill patients at risk of deficiency<|>8)\n<|COMPLETE|>", "input": "MANY entities and relationships were missed in the last extraction. Remember to ONLY emit entities that match any of the previously extracted types. Add them below using the same format:\n", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": [{"role": "user", "content": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: mayoritaria de ácidos grasos derivados del aceite de oliva y no solo de soja.\n\nLa NP basada en el aceite de oliva es segura y bien tolerada en los pacientes críticos39.\n\nLas guías canadienses recomiendan reducir la carga de ácidos grasos omega-6 (emulsiones basadas en aceite de soja), aunque no existen suficientes datos para recomendar el tipo de lípidos a utilizar en su sustitución10.\n\nEn pacientes críticos con NP se recomienda evitar el uso de formulaciones lipídicas basadas únicamente en soja y utilizar preferentemente otras fuentes que disminuyan el aporte de soja/omega 6 por su perfil de seguridad (pruebas de calidad moderada, recomendación fuerte)45.\n\nEn pacientes con NP las fórmulas enriquecidas en omega-3 procedente de aceite de pescado, podrían disminuir las complicaciones infecciosas, días de estancia y de ventilación mecánica (pruebas de calidad baja, recomendación débil)45.\n\n### Aminoácidos\n\nEl principal objetivo de la administración de aminoácidos es aportar precursores para la síntesis proteica en tejidos con alto recambio, frenar la proteólisis y aportar aminoácidos esenciales. Una solución equilibrada debe contener 1,3-1,5 g aminoácidos/kg de peso real.\n\nNo existen suficientes datos para recomendar la suplementación con altas cantidades de aminoácidos de cadena ramificada en el paciente crítico10.\n\n### Micronutrientes\n\nToda NP debe incluir diariamente elementos traza. Los micronutrientes poseen importantes propiedades antioxidantes.\n\nLas consecuencias de las deficiencias agudas de micronutrientes no son fácilmente detectadas, y el cuadro clínico completo tarda semanas en desarrollarse. Se recomienda la monitorización periódica en los pacientes que permanecen en estado crítico con NP, con el fin de detectar y tratar deficiencias importantes.\n\nLos pacientes críticos presentan generalmente un estado hipermetabólico, con aumento de los requerimientos de estas sustancias.\n\nSe debe suplementar con tiamina intravenosa 100-300 mg/día durante los 3 primeros días de la NP en pacientes con riesgo de déficit de tiamina -alcohólicos y pacientes malnutridos-, para prevenir alteraciones neurológicas.\n\nLos electrolitos deben administrarse según las necesidades y la patología de base, y según monitorización diaria.\n\n### 5.2.7. Nutrientes específicos\n\n- Glutamina: En pacientes críticos con NP no se recomienda el empleo de Gln a dosis supra fisiológicas combinando enteral (30 g/día) y parenteral (0,35 g/kg/día); especialmente en pacientes con fracaso renal, hepático o fallo multiorgánico donde aumenta la mortalidad (pruebas de alta calidad, recomendación -para no usarla- fuerte).\n- En pacientes críticos con NP el uso de Gln a dosis moderadas (0,3-0,5 g/kg/día) podría asociarse a menor morbilidad infecciosa, días de estancia y ventilación mecánica (pruebas de calidad baja, recomendación débil)46.\n- Ácidos grasos omega 3: La adición de EPA y DHA procedente del aceite de pescado a las emulsiones lipídicas ha demostrado efectos beneficiosos disminuyendo la respuesta inflamatoria. Aumenta la proporción de EPA y DHA en las membranas celulares y disminuye la proporción de ácido araquidónico; así se reduce la síntesis de eicosanoides y citoquinas proinflamatorios47.\n\n### 5.2.8. Cuidados específicos\n\nDebe realizarse una monitorización estricta diaria de los niveles de glucemia para asegurar un adecuado control metabólico, de electrolitos (sodio, potasio, magnesio, fósforo) y de la función renal. La función hepática y los niveles de triglicéridos plasmáticos han de valorarse una o dos veces por semana, y los micronutrientes de manera periódica.\n\n### 5.2.9. Complicaciones\n\nLa NP por vía central se asocia a:\n\n- Neumotórax, sangrado o trombosis de la vía.\n- Infecciones relacionadas o no con el catéter.\n- Síndrome de realimentación: La administración de un exceso de hidratos de carbono, lípidos o calorías en pacientes previamente malnutridos puede inducir su aparición3.\n---\n550      BLOQUE: PATOLOGÍAS ESPECÍFICAS\n\n## 6. Nutrición en situaciones especiales en UCI\n\nLas guías de la ASPEN 7 establecen una serie de recomendaciones en situaciones especiales:\n\n### 6.1. Insuficiencia respiratoria\n\nEstos pacientes asocian de manera habitual mal manejo de líquidos, por lo que deben ser consideradas las formulaciones enterales con restr\n######################\nOutput:"}, {"role": "assistant", "content": "(\"entity\"<|>NP<|>ORGANIZATION<|>NP refers to nutritional support provided to critically ill patients, focusing on the administration of nutrients and monitoring of their needs.)\n##\n(\"entity\"<|>ASPEN<|>ORGANIZATION<|>ASPEN is an organization that provides guidelines for nutrition in special situations, particularly in critical care settings.)\n##\n(\"entity\"<|>GLUTAMINE<|>EVENT<|>Glutamine is a specific nutrient discussed in the context of its use and recommendations for critically ill patients.)\n##\n(\"entity\"<|>EPA<|>EVENT<|>EPA is an omega-3 fatty acid that is beneficial when added to lipid emulsions for critically ill patients.)\n##\n(\"entity\"<|>DHA<|>EVENT<|>DHA is another omega-3 fatty acid that, like EPA, has beneficial effects in critically ill patients.)\n##\n(\"entity\"<|>MICRONUTRIENTS<|>EVENT<|>Micronutrients are essential elements that must be included in nutritional support for critically ill patients to prevent deficiencies.)\n##\n(\"entity\"<|>AMINO ACIDS<|>EVENT<|>Amino acids are crucial for protein synthesis and are administered to critically ill patients to support their recovery.)\n##\n(\"relationship\"<|>ASPEN<|>NP<|>ASPEN provides guidelines for the nutritional support (NP) of critically ill patients<|>8)\n##\n(\"relationship\"<|>GLUTAMINE<|>NP<|>Glutamine is discussed in the context of its use in nutritional support for critically ill patients<|>6)\n##\n(\"relationship\"<|>EPA<|>NP<|>EPA is recommended for inclusion in nutritional support for critically ill patients<|>6)\n##\n(\"relationship\"<|>DHA<|>NP<|>DHA is recommended for inclusion in nutritional support for critically ill patients<|>6)\n##\n(\"relationship\"<|>MICRONUTRIENTS<|>NP<|>Micronutrients are essential components of nutritional support for critically ill patients<|>7)\n##\n(\"relationship\"<|>AMINO ACIDS<|>NP<|>Amino acids are a key part of nutritional support for critically ill patients<|>7)\n<|COMPLETE|>"}]}